Information Hub
Access guidance, webcasts and publications with commentaries using the ABS Information Hub. Search by classification or using keywords.
To view the webcasts from previous ABS Conferences, events and webinars you must be an ABS member and be logged in using your membership username and password.
Use this guidance key to help search the ABS Information Hub more effectively. Keywords are grouped under nine main themes that reflect key areas of clinical practice in breast care. By using these keywords to guide your search, you can quickly locate relevant guidelines, webcasts, publications and toolkits tailored to specific topics of interest.
Adjuvant & Neoadjuvant Treatment
- Adjuvant chemotherapy treatment guidelines
- Bisphosphonates
- Endocrine therapy
- Neoadjuvant therapy
- Radiotherapy
- Tumour profiling
Benign & Atypical Breast Disease
- Fibroadenoma management
- Gynaecomastia
- Management of nipple discharge
Breast & Oncoplastic Surgery
- Antibiotic Prophylaxis
- Axilla
- Biological & synthetic mesh assisted breast reconstruction
- Implant loss/ removal
- Lipomodelling
- Negative pressure wound dressings
- Oncoplastic breast reconstruction
- Prepectoral implant-based breast reconstruction
- Sentinel Lymph Node Biopsy
- Surgical margins
- Surgical site infections
- Surgical techniques
- Sutures
- Venous thromboembolism
- Wound drains
Breast Cancer Risk
- Contralateral mastectomy
- Management of high risk patients
- Risk reducing surgery
Breast Cancer Treatment
- Advanced breast cancer
- Early and locally advanced breast cancer
- Management of the older patient
- Management of the younger patient
- Pregnancy associated breast cancer
Cosmetic Surgery
- BIA ALCL
- Breast imaging before/ after aesthetic surgery
Post Treatment Surveillance & Care
- Follow up
- Hormone replacement therapy
- Lymphoedema
- Management of oestrogen deficiency symptoms
- Surveillance mammography
Screening & Diagnosis
- B3 lesions
- Imaging guidance
- QA guidelines
- Screening assessment
- Symptomatic diagnostic guidance
Service Guidance
- Breast cancer management quality standards
- Breast services standards
- Commissioning
- Consent
- COVID 19 service guidance
- Documentation
- MDT Meetings
- Outcomes in breast cancer
- Patient communication
- Paediatric breast patients
-
menu_book
Duration of adjuvant aromatase-inhibitor therapy in postmenopausal breast cancer
This prospective randomised trial assigned postmenopausal women with HR-positive breast cancer who had received 5 years of adjuvant endocrine therapy (n=3484) to receive either additional 2 or 5 years...
Michael Gnant et al | The New England Journal of Medicine
28.07.2021 | Added: 28.07.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine Therapy
menu_bookPublication menu_book -
menu_book
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
Andrew N.J Tutt et al | The New England Journal of Medicine
03.06.2021 | Added: 03.06.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Adjuvant treatment BRCA
menu_bookPublication menu_book